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Abstract
The extent of latent HIV-1 infection in blood T cells and monocytes of 23 seropositive individuals was examined using DNA
amplification (PCR) of HIV-1 sequences. Amplified DNA was
found in at least one cell type in all seropositives tested, including 13 asymptomatic, 5 ARC, and 5 AIDS patients. Amplification with two or more primer sets from the gag, enm, LTR occurred in 21 (91%) patients' T cells and 17 (74%) patients'
monocytes. However, amplification with the LTR primers in
monocytes was uncommon.
Among four patients tested, amplified DNA continued to be
detected after a greater than one thousand-fold dilution (< 500
cells) of both T cell and monocyte lysates. Repeat analysis after
7-9 mo in five seropositives yielded similar findings in T cells
and monocytes, but some variation in the efficacy of amplification with individual primers occurred. There was no difference
in those 10 patients who were taking AZT, compared to those
who were untreated.
Our results indicate that a fraction (< 1%) of both T cells
and monocytes in blood carry a latent infection in all stages of
HIV-1 disease and can serve as reservoirs throughout AZT
therapy. (J. Clin. Invest. 1991. 87:27-30.) Key words: HIV-1monocyte * T cell

Introduction
The ability of human immunodeficiency virus type- 1 (HIV- 1)
to establish a latent infection in blood cells contributes to the
spread of virus to multiple tissues and between individuals.
Recent reports indicate that a greater burden of both cell-associated and cell-free HIV- I can be detected in the blood of seropositive individuals than previously recognized (1, 2). The evidence from these studies is based upon measurement of HIV- I
production in a tissue culture system. Application of the polymerase chain reaction (PCR)', which can amplify one to a few
copies of the HIV-l genome within host cell DNA (3, 4), permits a more direct and sensitive examination of the extent of
latent infection, and in different cell types.
Using PCR, a recent study of AIDS patients reported that
CD4+ T cells, but not monocytes, were the major reservoir for
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1. Abbreviations used in this paper: ARC, AIDS-related complex; ASX,
no symptoms; PCR, polymerase chain reaction.
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latent HIV- 1 infection (5). We independently have surveyed
monocytes and T cells from seropositive individuals who have
AIDS, AIDS-related complex (ARC), or no symptoms (ASX)
using the PCR method. Our results confirm that some T cells
carry a latent infection in all stages ofdisease. However, we also
detect HIV- 1 DNA in enriched populations of monocytes,
even though productive infection may be difficult to elicit from
this cell population (6).

Methods
Venipuncture was performed on 23 HIV-I seropositive participants in
a longitudinal HIV study at the Rockefeller University Hospital. The
70- 100 ml of heparinized blood was distributed for complete blood cell
counts, CD4/CD8 T cell analysis, and cell separation. Blood from
known low risk seronegatives was obtained concomitantly to serve as

controls.
Cell separation. As previously described (7), blood mononuclear
cells were obtained from the interface of Ficoll-Paque gradients and
incubated with neuraminidase-treated sheep red blood cells at 4VC for
I h. T cells, which form rosettes with the red cells, were separated from
other mononuclear cells by a second Ficoll-Paque gradient. Contaminating Fc receptor-bearing monocytes were removed from the T cell
population by panning on bacteriologic petri dishes coated with purified human gamma-globulin (CooperBiomedical, Inc., West Chester,
PA) (7) or by adherence onto plastic dishes for I h at 370C.
To obtain monocytes, the T cell-depleted (nonrosetting) cells were
cultured in Teflon beakers for < 36 h and then adhered I h onto plastic
dishes. By culturing the cells before the adherence step we avoided
contaminating dendritic cells and B cells which are loosely adherent
immediately upon isolation but much less so after culture. The adherent cells were washed, incubated 15 min in 3 mM EDTA at 370C, and
gently pipetted or scraped from the plastic. CD4' or CD8+ T cells were
not detectable by FACScan flow cytometry (6).
Preparation of DNA lysates. Purified monocytes or T cells were
washed twice with PBS, resuspended at 107 cells per ml of lysis buffer
(10 mM Tris-HCI, pH 8.0, 1 mM EDTA, 0.001% Triton X-100,
0.0001% SDS, and 600 Mg/ml proteinase K) (Boehringer Mannheim
Biochemicals, Indianapolis, IN), and digested I h in a 600C waterbath.
The proteinase K then was inactivated at 95°C for 15 min. Lysates
were stored at -20°C until use in the PCR reaction.
DNA amplification. We chose three oligonucleotide primer pairs to
amplify HIV-1 sequences from conserved regions of the genome:
SK38/39, from a 1 14-bp region of gag (1551-1578 and 1638-1665);
SK29/30, from a 104-bp region of LTR (501-518; and SK68/69, from
a 141 -bp region of env (7801-7829 and 7922-7942) (4). Each tube for
PCR contained (delivered in the following order) 50 MI mineral oil, 50
Ml primer reaction mixture (see below), and 50 Ml DNA lysate (containing 5 x 105 cells or I 1Mg DNA). Primer and MgCl2 concentrations
were adjusted in the primer reaction mixture to achieve amplification
of the highest sensitivity without primer-dimer formation. The reaction mixture contained final amounts (for 100 ,l) of either SK38/39
(20 pmol each), SK29/30 (100 pmol each), or SK68/69 (50 pmol each),
in 10 mM Tris-HCI (pH 8.3), 50 mM KC1, 1.5 mM MgCI2 (4.0 mM
with SK68/69 primers), 0.01% (wt/vol) gelatin, 0.2 mM of each deoxyribonucleoside triphosphate (dATP, dGTP, dCTP, and dTTP), and
2 units of recombinant Thermus aquaticus (Taq) polymerase (Perkin
-
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Elmer Corp., Norwalk, CT). All samples were added to the tubes with a
positive displacement pipetteman, and care was taken to prevent cross
contamination of samples. DNA lysates from seronegatives were used
as negative controls in every PCR reaction. The H9 human T cell line
infected persistently with HTLV-IIIb (ATCC CRL8543) was diluted
with uninfected cells 100-1,000-fold for use as the positive control in
each reaction. DNA amplification was performed in a Perkin-Elmer
thermal cycler for 30 cycles, programmed to denature for I min at
95°C, anneal for I min at 55°C, and extend for 1.5 min at 72°C. To
complete polymerization of the amplified products, a 10-min extension at 72°C was added at the end of the 30 cycles. PCR products were
stored at 4°C.
Hybridization ofPCR products with HIV-I probes. Oligonucleotide
probes, derived from internally conserved sequences of the amplified
region, were used to detect the amplified products. These included
SK19 (gag), SK31 (LTR), and SK70 (env) (4). 35 pmol of each probe
was 5' labeled with radioactive 32-ATP (100 MCi) at 37°C for I h using
T4 polynucleotide kinase (Boehringer Mannheim Biochemicals). Unincorporated label was removed by elution over a Nensorb column
(NEN Dupont Products, Boston, MA).
The hybridization reaction contained 10 Ml PCR product and 5 Ml
probe mixture. The probe mixture consisted of 500,000 cpm of the
appropriate probe (I Ml), 150 mM NaCl (final concentration), and distilled H20. The samples were denatured at 95°C for 5 min and hybridized in solution for 10 min in a 56°C waterbath. The oligonucleotide
probe-target DNA heteroduplex was resolved by electrophoresis on a
10% polyacrylamide gel, operated at 200 V for 90 min. The characteristic gel retardation fragment representing the amplified HIV-I sequences were visualized by autoradiography after exposure to XAR
film (Eastman Kodak Co., Rochester, NY) with one intensifying screen
for 2-4 h at -70°C.

Sensitivity and specificity ofthe PCR analysis. Reaction conditions
of the PCR and hybridization allowed detection of amplified products
from HIV- I infected H9 cells (diluted with uninfected PBMC) at a level
< 5 cells per reaction. If no characteristic band was visualized, the
samples were considered negative. Samples were considered positive if
the characteristic gel retardation fragments were detected on the autoradiogram at a moderate to high intensity relative to an undetectable to
weak intensity in the negative control.
Samples which failed to amplify with all HIV primer sets were amplified with oligonucleotide primer pairs (GH26 and GH27, 50 pmol
each) from a conserved region of the HLA-DQa locus (8) to determine
if the DNA present in the lysate could be amplified. Amplified products
were resolved on a composite 3% NuSieve (FMC Bioproducts, Rockland, ME) and 1%agarose gel,.and visualized by ethidium bromide
staining. If PCR products were undetectable by this method, the samples were excluded from the study.

Results
The clinical parameters of the 23 HIV- 1 seropositive patients
are shown in Table I. The complete disease spectrum was represented among the group studied: 13 had no symptoms, 5 had
ARC, and 5 had AIDS. 10 patients had received AZT antiviral
therapy for at least 3 mo before venipuncture. Peripheral blood
CD4/CD8 T cell ratios were typically decreased (< 1.0).
Efforts to prevent sample contamination were important
-for distinguishing true positives with the PCR technique. The
gag and more particularly the env primers were more likely to
generate false positive PCR products, which emphasizes the

Table L Clinical Parameters and PCR Analysis of HI V-I Infection from 23 Seropositive Patients
Patient No.

Clinical
diagnosis

I
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

ARC
ASX
ASX
ARC
ASX
ASX
AIDS
AIDS
ASX
AIDS
ASX
ARC
ASX
AIDS
ARC
ASX
ASX
ASX
ASX
ASX
AIDS
ARC
ASX

Antiviral

CD4/CD8

T cells

treatment

cells/pl

gag/env/LTR*

Monocytes
gag/env/LTR*

AZT
AZT

207/1960
1109/1357
469/765
338/857
586/987
565/849

+/+/+/+/-

-/+/+/+/-

+/+/+

+/+/-

+/+/+
+/+/+
+/+/+

172/560
643/580
748/1016
252/1189
675/1073

+/+/+/+/-

-/+/+/+/-/+/+/+/+/+/+/+/+/+/-

368/1233
639/826
79/1215
282/2270
419/1100
397/761
283/742
741/1123
453/1424
204/974
240/525
768/916

+/+/+/-/+/-/+/+/-

AZT/ZOV

AZT/ZOV
AZT/ZOV
AZT/ZOV
AZT
AL721

AZT/ZOV
AZT/ZOV

+/+/+
+/-/+
+/+/+

+/+/+
+/+/+

+/+/+
+/+/+/+/+

+/+/+*

+/+/+
+/+/+
+/+/+

+/+/+*
+/+/-

* DNA amplification with SK38/39 (gag), SK68/69 (env), and SK29/30 (LTR) primers and hybridization with SK19 (gag), SK70 (env), and
SK31 (LTR) probes, respectively. Signal detected by autoradiography after 2-4 h exposure. t Amplification with LTR primers detected by autoradiography after 18 h only.
28

M. J.

McElrath, R. M. Steinman, and Z. A. Cohn

Analysis of equal numbers of unstimulated blood T cells
and monocytes from the infected patients by DNA amplification of HIV-specific sequences is shown in Table I. Amplified
HIV- I DNA was detected in at least one primer in all patients'
T cells and in 21/23 patients' monocytes. If DNA amplification
with two primer sets is considered sufficient to confirm HIV- 1
infection, this occurred in 21 out of 23 (91%) patients' T cells
and in 17 out of 23 (74%) patients' monocytes. Monocyte ly- 'Tsates
SW
_
but not T cell lysates from two patients (No. 12 and No.
lw
16), failed to amplify with HIV- 1 primers but did amplify with
the HLA primers GH26/27 (data not shown), and were therefore considered true negatives.
A typical example of the HIV- 1 amplified products with the
three primer sets detected by autoradiography is shown in Fig.
1 2 3 4
1 2 3 4
2 3 4
1. The signal was apparent in most cases after a 2-h exposure
and
was confirmed after a 4-h exposure. When present, the
b
C
signal intensity was generally similar for the two cell types using
the gag and env primers and corresponding probes. The majority of the T cell samples amplified with LTR primers. Only two
monocyte lysates amplified with the LTR primers; reaction
products were detected by autoradiography only after an 18-h
exposure, which suggests that the amplification may have occurred in a few contaminating T cells.
To assess the relative number of infected cells per sample,
serial 10-fold dilutions of the DNA lysates from four patients
(Nos. 4, 18, 21, 22) with seronegative PBMC lysates were pre_l.
pared for PCR. Autoradiography of the hybridized products
from patients No. 21 and No. 22 is shown in Fig. 2, and the
pattern was similar for patients No. 4 and No. 18. PCR products were detectable to at least a 1,000-fold dilution (500 cells
out of 500,000) in both the T cell and monocyte samples in all
four patients.
1 2 3 4
1 2 3 4
1 2 3 4
PCR analysis was repeated 7-9 mo later in five patients
whose
course ofdisease, CD4+ T cells, or management had not
b
C
significantly changed, and the results are shown in Table II.
HIV- I was detected again in all patients' T cells and in four out
Figure 1. HIV-1 amplified piroducts detected by autoradiography. (A)
T cells and (B) monocytes frc)m patient No. 21 with AIDS (lane 1),
of the five patients' monocytes, although there was some variapatient No. 18, ASX (lane 2), patient No. 10 with AIDS (lane 3), and
tion in amplification with individual primers.
patient No. 4 with ARC (lane 4). Amplification with primers (a)
SK68/69 (env), (b) SK38/39 (gag), and (c) SK29/30 (LTR). No
Discussion
fragments were detected by amplification of monocyte DNA with the
LTR primers (c).
DNA amplification with the PCR technique now affords the
opportunity to detect fewer than five copies of HIV- 1 DNA in
need to include a negative control with each analysis. The LTR
mononuclear cells. In our hands, there is some variability in
primers were less sensitive but overall more specific in detect- the detection of HIV- 1 by gagand env primers, which indicates
ing HIV- 1 infection, giving no false positives or primer-dimer
that at least two sets of primers should be used to confirm HIV
formation.
infection by the PCR method. It is not clear why the monocyte

A

._~~~~~~~

a

B

D~h

a

1
1

2 3 4 5 1

,

A
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B

C
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Figure 2. Amplification of 10-fold serial
dilutions of patient No. 21 (A, B) and patient
No. 22 (C, D) DNA lysates using the SK38/
39 primers and the SKI 9 end-labeled probe.
Autoradiography exposure: 3 h. (A, C) T
cells; (B, D) monocytes. (1) 5 x IO' cells; (2)
5 X 104 cells; (3) 5 x 103 cells; (4) 5 X 102
cells; (5) 5 x 10' cells.
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Table II. Repeat PCR Analysis of Five Patients for Detection
of HIV-I Infection
Patient No.

1

T cells
gag/env/LTR

Monocytes
gag/env/LTR

1) +/+/2) +/+/+

1 //
2) -/+/-

3

1) +/+/+

1) +/+/2) +/+/-

13

2) +/+/+
1) +/-/-

2) +/+/+

2) -f-/-

1) +/+/+
2) +/+/+
1) +/+/+
2) +/+/+

1)

17

20

1)
2) -/+/-

1) +/+/+
2) -/+/-

Data for the first venipuncture is the same as shown in Table I. The
second venipuncture was performed 7-9 mo later.

population failed to amplify with the LTR sequences (Table I,
Fig. 1), but we now wonder if these sequences may vary among
the various mononuclear cell types.
We found comparable levels of latent HIV-l infection in
the blood cells from 10 patients with early disease (CD4' T cell
counts > 500, Table I) as in those with more progressive disease. Also, AZT-treated individuals, like untreated individuals,
were found to have HIV- 1 infection in one or both cell types.
This finding using PCR analysis is in agreement with other
studies measuring viral production (1, 9).
Our evidence is that latent infection with HIV- 1 occurs in
both T cells and monocytes. This is in contrast to Schnittman
et al. (5) who noted that T cells were the principal reservoir.
This may reflect differences in the techniques to prepare monocytes. Schnittman et al. sorted with a MAb to the monocyte
antigen, CD 14. It is possible that latently infected cells were not
successfully sorted. Monocytes frequently are lost from the
sample because of adherence or clumping during cell sorting
procedures, or the latently infected monocyte may have low
levels of CD 14, an antigen which is subject to downregulation,
e.g., by exposure to lipopolysaccharide (Wright, S. W., personal
communication). We doubt that our monocytes, which were
enriched by plastic adherence after 1-2 d in culture, were significantly contaminated with T cells, because CD3' cells were not
detectable by FACS analyses (data not shown), and because the
level of infection in our T and monocyte populations seemed
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similar by dilution analysis (Fig. 2). Our findings regarding the
difficulty of eliciting a productive HIV-l infection from monocytes relative to T cells (6) are similar those of others (5). On the
other hand, it may be important to learn to approach the latent
infection of the monocyte fraction, if one is to devise better
strategies to prevent the spread of HIV- I infection within and
between seropositive individuals.
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